Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Oct ETF OCTW Stock Holding History
Bought
Maintained
Sold
Other funds holding OCTW
KAS
SWM
EWM
PA
SRA
MFN
SB
CRWM
DWM
Cambridge Investment Research Advisors's OCTW Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its AllianzIM U.S. Equity Buffer20 Oct ETF (OCTW) stake by 1.8% in Q2 2026, selling an estimated $33K and leaving 45,558 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.
Cambridge Investment Research Advisors first reported a position in OCTW in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.91M in Q4 2025. 34 funds tracked by Wall St. Rank hold OCTW as of Q2 2026.
- Cambridge Investment Research Advisors held 45,558 shares of AllianzIM U.S. Equity Buffer20 Oct ETF worth $1.86M as of Q2 2026.
- Cambridge Investment Research Advisors sold 820 AllianzIM U.S. Equity Buffer20 Oct ETF shares in Q2 2026, an estimated $33K.
- AllianzIM U.S. Equity Buffer20 Oct ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1743 holding.
- Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Oct ETF in Q4 2021 and has held it in 19 quarters since.
- Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer20 Oct ETF position peaked at $1.91M in Q4 2025.
- 34 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Oct ETF as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.